Sugi Predict
/ Targets
/ CSPP1
Top predicted compounds (top 20 by supporting neighbours, then confidence)
| Compound | Confidence | Supporting neighbours |
|---|
Clinical trials — most relevant to CSPP1 by text similarity (a relevance ranking, not an exhaustive list)
| Trial | Phase | Status |
|---|
| Comparative Analysis of the Efficacies in Neoadjuvant Chemotherapy of Breast Cancer |
PHASE3 | COMPLETED |
| Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU) |
PHASE2/PHASE3 | ACTIVE_NOT_RECRUITING |
| Dimethyl Fumarate in Adrenomyeloneuropathy |
PHASE2/PHASE3 | ACTIVE_NOT_RECRUITING |
| TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC) |
PHASE1/PHASE2 | RECRUITING |
| Vit D and Peripheral Neuropathy in Taxane Naive Patients |
PHASE2 | UNKNOWN |
| Sirolimus Treatment in Patients With Autosomal Dominant Polycystic Kidney Disease: Renal Efficacy and Safety |
PHASE2 | COMPLETED |
| Therapy With Docetaxel and ZD1839 for Patients Who Have Advanced Breast Cancer |
PHASE2 | COMPLETED |
| Eribulin in Angiosarcoma and Epithelioid Hemangioendothelioma (EHE) |
PHASE2 | ACTIVE_NOT_RECRUITING |
| Vinorelbine in Relapsed Platinum Resistant or Refractory C5 High Grade Serous, Endometrioid, or Undifferentiated Primary Peritoneum, Fallopian Tube or Ovarian Cancer |
PHASE2 | UNKNOWN |
| Study of ABT-751 in Patients With Refractory Hematologic Malignancies |
PHASE1 | COMPLETED |
| Phase I Study of Oral BAY 1217389 in Combination With Intravenous Paclitaxel |
PHASE1 | COMPLETED |
| Phase I Study to Assess the Safety, Pharmacokinetics, & Pharmacodynamics of GSK923295 in Subjects w/ Refractory Cancer |
PHASE1 | COMPLETED |
| A Study of Investigational Drug CFI-402257 in Patients With Advanced Solid Tumors |
PHASE1 | COMPLETED |
| SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes |
PHASE1 | COMPLETED |
| Exploratory Evaluation of [11C]MPC6827 |
EARLY_PHASE1 | COMPLETED |
| Importance of the Microtubule Cytoskeleton in Oocyte Competence |
nan | COMPLETED |
| PCM1-JAK2 in Therapy Related Neoplasms |
nan | UNKNOWN |
| The Relation of Microtubule-Associated Protein 2 and Cell Migration |
nan | UNKNOWN |
| Post Market Surveillance & Post Market Clinical Follow up, International, Medical Registry to Confirm the Safety and the Performance of the Anecova Intra Uterine Culture Device |
nan | WITHDRAWN |
| Genetic Study of Patients With Primary Ciliary Dyskinesia |
nan | COMPLETED |
| Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM) |
nan | COMPLETED |
| Evaluation of a Novel PET Radioligand to Image OGA |
nan | COMPLETED |
| Blood-based Biomarkers for the Prognosis of Sports Related Concussion |
nan | COMPLETED |
| Better Delineation of CDK13 Related Phenotype and Epigenetic Signature. |
nan | UNKNOWN |
| Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease |
nan | RECRUITING |
| Infants With Agenesis of the Corpus Callosum |
nan | COMPLETED |
| Diagnosis of Primary Ciliary Dyskinesia |
nan | COMPLETED |
| Predicting Postoperative Delirium Using EEG, Genetics and Neurobiomarkers of Cerebral Injury |
nan | COMPLETED |
| PCD New Gene Discovery |
nan | COMPLETED |
| Genetics of Primary Ciliary Dyskinesia |
nan | COMPLETED |
Related proteins — ESM-2 sequence neighbours (a CSPP1 binder may also engage these)